The University of Chicago Header Logo

Connection

Deric Park to Immunotherapy

Back to Details
This is a "connection" page, showing publications Deric Park has written about Immunotherapy.
Deric Park
Connection Strength
0.642
Immunotherapy
  1. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019 10 17; 4(20).
    View in: PubMed
    Score: 0.443
  2. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018 06 11; 6(1):51.
    View in: PubMed
    Score: 0.101
  3. Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases. BMC Cancer. 2018 03 01; 18(1):239.
    View in: PubMed
    Score: 0.099
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.